Integrative Assessment of the Diagnostic Significance of the microRNA (-21, -29a, -133a) Panel in Patients With

E I Tashina1, E V Privalova1, V Yu Kaplunova1

  • 1Sechenov First Moscow State Medical University, Moscow.

Kardiologiia
|February 11, 2026
PubMed
Abstract

Insights

A panel of microRNAs (miRNAs) can help diagnose hypertrophic cardiomyopathy (HCM). Specific miRNA levels, including increased microRNA-21 and decreased microRNA-29a, show diagnostic potential for HCM.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Biomarker Discovery

Background:

  • Hypertrophic cardiomyopathy (HCM) is a primary genetic heart disease.
  • Accurate diagnosis and risk stratification are crucial for managing HCM.
  • Novel diagnostic markers are needed to improve early detection and patient outcomes.

Purpose of the Study:

  • To investigate the diagnostic value of circulating microRNA panel (-21, -29a, -133a) in patients with HCM.
  • To compare microRNA expression levels between HCM patients and a control group with arterial hypertension.
  • To assess the potential of these microRNAs as auxiliary diagnostic markers for HCM.

Main Methods:

  • A comparative study included 40 patients with confirmed HCM and 40 age- and sex-matched controls.
  • Comprehensive cardiac assessments included ECG, echocardiography, and Holter monitoring.
  • Plasma levels of microRNAs -21, -29a, and -133a were quantified using real-time PCR.

Main Results:

  • Significant differences in microRNA expression were observed between HCM patients and controls.
  • MicroRNA-21 was significantly increased (p<0.001), while microRNA-29a (p<0.001) and microRNA-133a (p<0.001) were significantly decreased in HCM patients.
  • Receiver Operating Characteristic (ROC) analysis showed high diagnostic accuracy for microRNA-21 (AUC=0.887) and microRNA-29a (AUC=0.884).

Conclusions:

  • The microRNA panel (-21, -29a, -133a) demonstrates significant diagnostic potential for HCM.
  • Elevated microRNA-21 and reduced microRNA-29a correlate with myocardial fibrosis.
  • Suppressed microRNA-133a indicates hypertrophic remodeling, suggesting these miRNAs as promising auxiliary markers for HCM.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
526
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
589
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
587
Wood Panel Products01:18

Wood Panel Products

Wood panel products are essential materials used in construction for applications such as flooring, siding, and roofing, typically available in standard dimensions of 4 feet by 8 feet, with thicknesses varying from one-quarter of an inch to one and one-eighth inches. Among the most common types of wood panels is plywood, which is produced by gluing multiple layers of thin wood veneers under pressure. The grain of the outer veneers runs lengthwise, while the grains of the interior layers run...
411